Héctor Padilla, Vice President at Covalon Technologies

episode

Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

Gerardo Noriega, President & CEO at PercAssist, Inc 56 min · 07 Aug 2026

Matt DeNardo, Chief Product Officer at Axoft 39 min · 11 Jul 2026

Daniel Chen, Founder and CEO at Synthetic Design Lab 53 min · 15 Jun 2026

Shareef Mahdavi, Founder at PX Movement 55 min · 05 Jun 2026

All episodes from Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere →

Report any issue

Source

Recorded09 May 2020

Publisherfeeds.buzzsprout.com

Handlerec:763008

Show notes

Send us a textHéctor Padilla is Vice President at Covalon Technologies, Strategic Markets focusing on developing commercial and go-to-market strategies for new and existing markets globally. He has more than twenty-seven years of experience in marketing, sales, and business development for Fortune 100 companies and, small and medium enterprises. Héctor built a large network of partner distributors across Latin America to commercialize Covalon’s portfolio of advanced wound care and infection prevention unique products while developing strong relationships with key opinion leaders and experts. Héctor holds a BA in Business administration from the Jose Maria Vargas University in Caracas, Venezuela, and a Master in Business Administration, with a concentration in marketing from the Sawyer Business School at Suffolk University in Boston, MA.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.